The Biological Imaging Service offers integrated technologies and expertise through three interrelated services -Electron Microscopy (EM), Light Microscopy (LM) and Histology - and has been supported as an integrated Service by the Cancer Center support grant (CCSG) for the past five years. Biological Imaging provides fee-for-service access to Cancer Center members at the level they require, ranging from unassisted instrument access to full-service sample preparation and data acquisition and analysis. Use of these services has increased an average of 421 percent since the first year of the current CCSG funding period. Biological Imaging occupies a centrally located, 1,806 sq. ft. facility and is fit out with state-of-the-art instrumentation. To meet the needs of Cancer Center scientists engaged in a wide range of scientific endeavors, Biological Imaging Services have grown to include standard transmission and scanning electron microscopy, immunoelectron microscopy (enzymatic and gold labeling), nucleic acid visualization, SEM freeze-fracture, and immunohistochemistry (enzymatic and fluorescence). Confocal microscopy and fluorescence microscopy, computerized image analysis, in situ hybridization (calorimetric and fluorescence), and laser-capture microscopy are routinely available. All types of routine and specialized histological stains are available, affording the Center?s staff access to high-quality diagnostic slides for evaluation of lesions. Technicians staffing the Service are experienced in at least two of the three disciplines that comprise the Service. The result has been the expansion and enhancement of highly integrated microscopy services provided to Cancer Center researchers. John J. Eppig, Ph.D., a developmental and reproductive biologist, has served as the Scientific Staff Supervisor since 1995 and EM supervisor since 1985. Dr. Eppig communicates regularly with the User Group and service personnel to insure that users have equitable service access and that their needs are met in the most efficient, cost effective and technically current manner.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA034196-20
Application #
6652225
Study Section
Project Start
2002-08-01
Project End
2003-07-31
Budget Start
Budget End
Support Year
20
Fiscal Year
2002
Total Cost
Indirect Cost
Name
Jackson Laboratory
Department
Type
DUNS #
042140483
City
Bar Harbor
State
ME
Country
United States
Zip Code
04609
Becker, Timothy; Lee, Wan-Ping; Leone, Joseph et al. (2018) FusorSV: an algorithm for optimally combining data from multiple structural variation detection methods. Genome Biol 19:38
Wang, Qianghu; Hu, Baoli; Hu, Xin et al. (2018) Tumor Evolution of Glioma-Intrinsic Gene Expression Subtypes Associates with Immunological Changes in the Microenvironment. Cancer Cell 33:152
Richter, Wolfgang F; Christianson, Gregory J; Frances, Nicolas et al. (2018) Hematopoietic cells as site of first-pass catabolism after subcutaneous dosing and contributors to systemic clearance of a monoclonal antibody in mice. MAbs 10:803-813
Tamura, Ryo; Yoshihara, Kosuke; Saito, Tetsuya et al. (2018) Novel therapeutic strategy for cervical cancer harboring FGFR3-TACC3 fusions. Oncogenesis 7:4
Rutherford, Sarah C; Fachel, Angela A; Li, Sheng et al. (2018) Extracellular vesicles in DLBCL provide abundant clues to aberrant transcriptional programming and genomic alterations. Blood 132:e13-e23
Barthel, Floris P; Wesseling, Pieter; Verhaak, Roel G W (2018) Reconstructing the molecular life history of gliomas. Acta Neuropathol 135:649-670
Winer, Benjamin Y; Shirvani-Dastgerdi, Elham; Bram, Yaron et al. (2018) Preclinical assessment of antiviral combination therapy in a genetically humanized mouse model for hepatitis delta virus infection. Sci Transl Med 10:
Kim, Hyunsoo; Kumar, Pooja; Menghi, Francesca et al. (2018) High-resolution deconstruction of evolution induced by chemotherapy treatments in breast cancer xenografts. Sci Rep 8:17937
Schechter, Lisa M; Creely, David P; Garner, Cherilyn D et al. (2018) Extensive Gene Amplification as a Mechanism for Piperacillin-Tazobactam Resistance in Escherichia coli. MBio 9:
Barthel, Floris P; Johnson, Kevin C; Wesseling, Pieter et al. (2018) Evolving Insights into the Molecular Neuropathology of Diffuse Gliomas in Adults. Neurol Clin 36:421-437

Showing the most recent 10 out of 1156 publications